Real-world evidence suggests that furosemide use is associated with reduced sepsis-related coagulopathy and favorable organ outcomes. These findings generate a biologically plausible hypothesis consistent with Na +-K +-2Cl - cotransporter 1 (NKCC1)-related antioxidant and anti-inflammatory pathways observed in preclinical models, warranting confirmation in prospective trials.
Hung et al. (Tue,) studied this question.